Topics: Antipsychotics

They used to be called “depot” antipsychotics, but the powers that be have renamed them “long acting injectables” (LAIs), presumably to help remove some of the stigma associated with their use. But no matter what you call them, suddenly every drug company is racing to introduce its own LAI neuroleptic.

An index of the topics covered in 2010.

Psychiatrists often have patients who come in bearing long lists of medications for various comorbid conditions. Is there any evidence that we should evaluate and treat such patients differently than patients without medical illnesses?

Topics: Psychotherapy

Medication discontinuation is alarmingly common among patients with schizophrenia—it may range anywhere from 42% to 74%.

Topics: Antidepressants | Dementia

Due to their inhibition of both serotonin and norepinephrine reuptake, the SNRIs venlafaxine (Effexor) and duloxetine (Cymbalta) have been billed as possessing an advantage over SSRIs.

Topics: Natural Medications

Given that taking B vitamins can lower plasma homocysteine levels, a group of researchers recently examined whether supplemental B vitamins could low the rate of brain atrophy in elderly people with mild cognitive impairment (MCI).